Johnson & Johnson reported $7.96B in Cost of Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
AstraZeneca AZN:LN 3068M 756M
Bayer BAYN:GR € 3685M 202M
Cooper Companies COO:US $ 268.8M 11.6M
Medtronic MDT:US $ 2459M 7M
Novartis NOVN:VX SF 4000M 152M
Teva Pharmaceutical TEVA:IT 1.98B 14M
Zoetis ZTS:US $ 596M 14M